Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Genetic overlap between mood instability and alcohol-related phenotypes suggests shared biological underpinnings
    Published on 2022-08-11
    3 years ago
  • mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder
    Published on 2022-08-09
    3 years ago
  • Emotional numbing in PTSD is associated with lower amygdala reactivity to pain
    Published on 2022-08-09
    3 years ago
  • Regulation of social hierarchy learning by serotonin transporter availability
    Published on 2022-08-09
    3 years ago
  • Integrating human brain proteomic data with genome-wide association study findings identifies novel brain proteins in substance use traits
    Published on 2022-08-08
    3 years ago
  • Hippocampus and amygdala fear memory engrams re-emerge after contextual fear relapse
    Published on 2022-08-08
    3 years ago
  • Beyond the hypothalamus: roles for insulin as a regulator of neurotransmission, motivation, and feeding
    Published on 2022-08-06
    3 years ago
« Previous 1 … 107 108 109 110 111 … 143 Next »
Journal of Psychopharmacology
  • Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia
    Published on 2019-07-11
    6 years ago
  • Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
    Published on 2019-07-11
    6 years ago
  • Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model
    Published on 2019-07-10
    6 years ago
  • Differential rewarding effects of electrical stimulation of the lateral hypothalamus and parabrachial complex: Functional characterization and the relevance of opioid systems and dopamine
    Published on 2019-07-08
    6 years ago
  • A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia
    Published on 2019-07-02
    6 years ago
  • Brain circuitry, behavior, and cognition: A randomized placebo-controlled trial of donepezil in fragile X syndrome
    Published on 2019-07-02
    6 years ago
  • Resting-state dynamics as a neuromarker of dopamine administration in healthy female adults
    Published on 2019-06-27
    6 years ago
« Previous 1 … 107 108 109 110 111 … 123 Next »
European Neuropsychopharmacology
  • Transcriptome profiling in adult attention-deficit hyperactivity disorder
    Published on 2020-11-25
    5 years ago
  • P.859COVID-19 lockdown in people with severe mental disorders in Spain: do they have a specific psychological reaction?
    Published on 2020-11-25
    5 years ago
  • P.862Impact of the coronavirus crisis on anxiety and depressive symptoms throughout Spain
    Published on 2020-11-25
    5 years ago
  • P.845The effect of antipsychotic therapy on the social functioning of patients with paranoid schizophrenia
    Published on 2020-11-25
    5 years ago
  • P.860Compassion fatigue, burnout and hopelessness of the health workers in COVID-19 pandemic emergency
    Published on 2020-11-25
    5 years ago
  • P.846Definitions of antipsychotic response based on clinician-rated instruments in patients with delusional disorder: a systematic review
    Published on 2020-11-25
    5 years ago
  • P.816Early onset of action for trazodone antidepressant activity: insight into potential molecular mechanism
    Published on 2020-11-25
    5 years ago
« Previous 1 … 107 108 109 110 111 … 144 Next »

   Pharma Pub